CytoSorbents Corporation (CTSO)

[techxen]

Tweet from Palex at ILTS 2018 Annual Congress

This picture was tweeted by Palex at the Cytosorbents booth at International Liver Transplantation Society yesterday. I translated it to English:

"Come visit us at the @CytoSorbents stand at the # ILTS2018 congress in #Lisboa and meet #Cytosorb, the bridge therapy for the elimination of #bilirubin, ammonium and bile acids and #cytokines!"

Nuestros compañeros de @PalexCuiCli están junto a @CytoSorbents en el #ILTS2018 de #Lisboa. ¡No olvidéis pasar a saludar por su stand! https://t.co/qZO25Mah30

— Palex España (@Palex_Espana) May 24, 2018

From the press release regarding Palex distributorship:

Dr. Phillip Chan, Chief Executive Officer of CytoSorbents stated, "Palex has an outstanding reputation of launching new innovative products across a breadth of different treatment areas to physicians and hospitals in these countries. In a difficult but improving economy, it was particularly important to us to work with an established market leader that intimately understands the Spanish and Portuguese hospital systems. We welcome Palex to the CytoSorb® family."

Spain has a population of 48 million people, making it the fifth largest country in the European Union. Portugal has a population of 10.5 million people. The public healthcare system in Spain is fully-funded by the government and supplemented through social security payments, while private healthcare also co-exists. Spain spends approximately 10% of its gross domestic product on healthcare.